Canada Pharmaceutical Market 2030: Innovations Driving Growth
The Canadian pharmaceutical market was valued at USD 51.56 billion in 2024 and is projected to reach USD 76.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2030. The market growth is driven by multiple factors including an aging population, rising healthcare expenditures, increased demand for innovative medications, and a strong emphasis on research and development. Furthermore, supportive government policies that enhance healthcare access and investments in biotechnology are contributing significantly to the sector’s expansion. Collectively, these elements foster growth and innovation within Canada’s pharmaceutical industry. A key influence on market dynamics is Canada’s aging population. The number of individuals aged 65 and over is expected to reach 5.1 million in the next decade, significantly increasing the demand for pharmaceutical products and healthcare services. Older adults typically require medications to manage chro...